※Vaccinex: "Vaccinex Reports Third Quarter 2018 Financial Results and Provides Corporate Update". (11/13)
Financial Results for the Three and Nine Months Ended September 30, 2018:
・Revenue: Revenue recognized during the quarter was principally derived from collaboration agreements with Surface Oncology, Merck and Heptares.